Polycythemia Vera [clinicaltrials_resource:b424416ca4721b69bbc26262d5fcced6]
Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction [clinicaltrials:NCT00025415]clinicaltrials:NCT00038675Imatinib Mesylate in Treating Patients With Myelofibrosis [clinicaltrials:NCT00039416]Tipifarnib in Treating Patients With Myelofibrosis and Myeloid Metaplasia [clinicaltrials:NCT00047190]clinicaltrials:NCT00052520Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer [clinicaltrials:NCT00089011]Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer [clinicaltrials:NCT00112593]clinicaltrials:NCT00227591Efficacy and Safety of Pegylated Interferon Alfa in Polycythemia Vera [clinicaltrials:NCT00241241]clinicaltrials:NCT00255346Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders [clinicaltrials:NCT00357305]clinicaltrials:NCT00381550Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders [clinicaltrials:NCT00397813]Effects of Imatinib Mesylate in Polycythemia Vera [clinicaltrials:NCT00430066]Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders [clinicaltrials:NCT00433862]Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome [clinicaltrials:NCT00445744]clinicaltrials:NCT00509899A Safety Study of XL019 in Adults With Myelofibrosis [clinicaltrials:NCT00522574]Dasatinib in Polycythemia Vera [clinicaltrials:NCT00538980]Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis [clinicaltrials:NCT00586651]Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders [clinicaltrials:NCT00588991]A Phase 1 Study of XL019 in Adults With Polycythemia Vera [clinicaltrials:NCT00595829]Correlative Biomarker Study in Patients With Myeloproliferative Disorders [clinicaltrials:NCT00665067]Familial Myeloproliferative Disorders [clinicaltrials:NCT00666289]Research Tissue Bank [clinicaltrials:NCT00666549]CEP-701 (Lestaurtinib) in Myelofibrosis [clinicaltrials:NCT00668421]clinicaltrials:NCT00715247clinicaltrials:NCT00726232A Phase 1/2 Study of Oral SB1518 in Subjects With Chronic Idiopathic Myelofibrosis [clinicaltrials:NCT00745550]A Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia [clinicaltrials:NCT00866762]clinicaltrials:NCT00890747Phase II Study of GIVINOSTAT (ITF2357) in Combination With Hydroxyurea in Polycythemia Vera [clinicaltrials:NCT00928707]Clopidogrel and Aspirin for the Treatment of Polycythemia Vera [clinicaltrials:NCT00940784]clinicaltrials:NCT00946270Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis [clinicaltrials:NCT01014546]clinicaltrials:NCT01038856Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer [clinicaltrials:NCT01053494]clinicaltrials:NCT01120821A Study in Myeloproliferative Disorders [clinicaltrials:NCT01134120]Safety Study of Pegylated Interferon Alpha 2b to Treat Polycythemia Vera [clinicaltrials:NCT01193699]
condition [clinicaltrials_vocabulary:condition]
Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction [clinicaltrials:NCT00025415]clinicaltrials:NCT00038675Imatinib Mesylate in Treating Patients With Myelofibrosis [clinicaltrials:NCT00039416]Tipifarnib in Treating Patients With Myelofibrosis and Myeloid Metaplasia [clinicaltrials:NCT00047190]clinicaltrials:NCT00052520Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer [clinicaltrials:NCT00089011]Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer [clinicaltrials:NCT00112593]clinicaltrials:NCT00227591Efficacy and Safety of Pegylated Interferon Alfa in Polycythemia Vera [clinicaltrials:NCT00241241]clinicaltrials:NCT00255346Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders [clinicaltrials:NCT00357305]clinicaltrials:NCT00381550Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders [clinicaltrials:NCT00397813]Effects of Imatinib Mesylate in Polycythemia Vera [clinicaltrials:NCT00430066]Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders [clinicaltrials:NCT00433862]Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome [clinicaltrials:NCT00445744]clinicaltrials:NCT00509899A Safety Study of XL019 in Adults With Myelofibrosis [clinicaltrials:NCT00522574]Dasatinib in Polycythemia Vera [clinicaltrials:NCT00538980]Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis [clinicaltrials:NCT00586651]Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders [clinicaltrials:NCT00588991]A Phase 1 Study of XL019 in Adults With Polycythemia Vera [clinicaltrials:NCT00595829]A Dose-escalation Study of the Safety and Tolerability of Orally Administered TG101348 in Patients With Myelofibrosis [clinicaltrials:NCT00631462]Correlative Biomarker Study in Patients With Myeloproliferative Disorders [clinicaltrials:NCT00665067]Familial Myeloproliferative Disorders [clinicaltrials:NCT00666289]Research Tissue Bank [clinicaltrials:NCT00666549]CEP-701 (Lestaurtinib) in Myelofibrosis [clinicaltrials:NCT00668421]clinicaltrials:NCT00669578clinicaltrials:NCT00715247clinicaltrials:NCT00726232A Phase 1/2 Study of Oral SB1518 in Subjects With Chronic Idiopathic Myelofibrosis [clinicaltrials:NCT00745550]A Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia [clinicaltrials:NCT00866762]clinicaltrials:NCT00890747Study to Assess the Safety of AZD1480 in Patients With Myeloproliferative Diseases [clinicaltrials:NCT00910728]Phase II Study of GIVINOSTAT (ITF2357) in Combination With Hydroxyurea in Polycythemia Vera [clinicaltrials:NCT00928707]Safety and Efficacy of Panobinostat in Patients With Primary Myelofibrosis [clinicaltrials:NCT00931762]clinicaltrials:NCT00934544Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET) [clinicaltrials:NCT00935987]Clopidogrel and Aspirin for the Treatment of Polycythemia Vera [clinicaltrials:NCT00940784]clinicaltrials:NCT00946270
condition browse [clinicaltrials_vocabulary:condition-browse]
Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction [clinicaltrials:NCT00025415]clinicaltrials:NCT00038675Imatinib Mesylate in Treating Patients With Myelofibrosis [clinicaltrials:NCT00039416]Tipifarnib in Treating Patients With Myelofibrosis and Myeloid Metaplasia [clinicaltrials:NCT00047190]clinicaltrials:NCT00052520Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer [clinicaltrials:NCT00089011]Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer [clinicaltrials:NCT00112593]clinicaltrials:NCT00227591Efficacy and Safety of Pegylated Interferon Alfa in Polycythemia Vera [clinicaltrials:NCT00241241]clinicaltrials:NCT00255346Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders [clinicaltrials:NCT00357305]clinicaltrials:NCT00381550Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders [clinicaltrials:NCT00397813]Effects of Imatinib Mesylate in Polycythemia Vera [clinicaltrials:NCT00430066]Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders [clinicaltrials:NCT00433862]Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome [clinicaltrials:NCT00445744]clinicaltrials:NCT00509899A Safety Study of XL019 in Adults With Myelofibrosis [clinicaltrials:NCT00522574]Dasatinib in Polycythemia Vera [clinicaltrials:NCT00538980]Open-Label Study of Oral CEP-701 (Lestaurtinib) in Patients With Polycythemia Vera or Essential Thrombocytosis [clinicaltrials:NCT00586651]Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders [clinicaltrials:NCT00588991]A Phase 1 Study of XL019 in Adults With Polycythemia Vera [clinicaltrials:NCT00595829]A Dose-escalation Study of the Safety and Tolerability of Orally Administered TG101348 in Patients With Myelofibrosis [clinicaltrials:NCT00631462]Correlative Biomarker Study in Patients With Myeloproliferative Disorders [clinicaltrials:NCT00665067]Familial Myeloproliferative Disorders [clinicaltrials:NCT00666289]Research Tissue Bank [clinicaltrials:NCT00666549]CEP-701 (Lestaurtinib) in Myelofibrosis [clinicaltrials:NCT00668421]clinicaltrials:NCT00669578clinicaltrials:NCT00715247clinicaltrials:NCT00726232A Phase 1/2 Study of Oral SB1518 in Subjects With Chronic Idiopathic Myelofibrosis [clinicaltrials:NCT00745550]A Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia [clinicaltrials:NCT00866762]clinicaltrials:NCT00890747Study to Assess the Safety of AZD1480 in Patients With Myeloproliferative Diseases [clinicaltrials:NCT00910728]Phase II Study of GIVINOSTAT (ITF2357) in Combination With Hydroxyurea in Polycythemia Vera [clinicaltrials:NCT00928707]Safety and Efficacy of Panobinostat in Patients With Primary Myelofibrosis [clinicaltrials:NCT00931762]clinicaltrials:NCT00934544Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET) [clinicaltrials:NCT00935987]Clopidogrel and Aspirin for the Treatment of Polycythemia Vera [clinicaltrials:NCT00940784]clinicaltrials:NCT00946270
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Polycythemia Vera [clinicaltrials_resource:b424416ca4721b69bbc26262d5fcced6]
Bio2RDF identifier
b424416ca4721b69bbc26262d5fcced6
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:b424416ca4721b69bbc26262d5fcced6
identifier
clinicaltrials_resource:b424416ca4721b69bbc26262d5fcced6
title
Polycythemia Vera
@en
type
label
Polycythemia Vera [clinicaltrials_resource:b424416ca4721b69bbc26262d5fcced6]
@en
Polycythemia Vera